In re: Entresto (Sacubitril/Valsartan) Patent Litigation
Case Number:
1:20-md-02930
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Multi Party Litigation:
Multi-district Litigation
Judge:
Firms
- Abrams & Bayliss
- Duane Morris
- Heyman Enerio
- Kratz & Barry
- McCarter & English
- Morris James
- Parker Poe
- Perkins Coie
- Phillips McLaughlin
- Pinckney Weidinger
- Potter Anderson
- Richards Layton
- Schrader Companion
- Shaw Keller
- Smith Katzenstein
- Stamoulis & Weinblatt
- Steptoe & Johnson PLLC
- Venable LLP
- Young Conaway
Companies
- Alembic
- Alembic Pharmaceuticals Ltd.
- Alkem Laboratories Ltd.
- Aurobindo Pharma Ltd.
- Biocon Ltd.
- Dr. Reddy's Laboratories Ltd.
- Hetero Labs Ltd.
- Laurus Labs Pvt Ltd.
- Lupin Ltd.
- Macleods Pharmaceuticals Ltd.
- Teva Pharmaceutical Industries Ltd.
- Torrent Pharmaceuticals Ltd.
- Viatris Inc.
- Zydus Pharmaceuticals Inc.
Sectors & Industries:
-
September 28, 2022
Novartis Gets Counterclaims Cut From Heart Drug Patent MDL
A Delaware federal judge has thrown out declaratory judgment counterclaims lodged against Novartis by two generic-drug makers in multidistrict patent litigation over Novartis' heart medication Entresto, determining that the court lacks subject matter jurisdiction.
- ← Previous
- 1
- 2
- Next →